'Trojan horse' proteins are step forward for nanoparticle-based anti-cancer and anti-dementia therapeutic approaches

December 11, 2014
Scanning electron microscopy images of pristine (A and B) and CMC-coated (C and D) Fe-MWNTs showing high purity of the pristine samples and high dispersion of the functionalized samples. The dispersions are very stable (non-sedimenting).

Scientists at Brunel University London have found a way of targeting hard-to-reach cancers and degenerative diseases using nanoparticles, but without causing the damaging side effects the treatment normally brings.

In a huge step forward in the use of nanomedicine, the research helped discover proteins in the blood that disguise so they are absorbed into cells without causing inflammation and destroying healthy cells.

Two studies, Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages and Complement deposition on nanoparticles can modulate immune responses by macrophage, B and T cells, found that carbon nanotubes (CNTs) triggered a chain reaction in the complement system, which is part of the innate immune system and is responsible for clearing pathogens and toxins.

The team, led by Dr Uday Kishore of the Centre for Infection, Immunity and Disease Mechanisms, found the entire complement system was activated, from C1 at the start to C5 at the end. This in turn activated the cell-killing membrane attack complex.

In principle, this should have caused an acute allergic, inflammatory reaction. However the opposite was true.

The interaction between CNTs and C1q (a starter- for complement) was anti-inflammatory. This suggests that either coating nanoparticles or healthy tissue with could reduce tissue damage and help treat inflammatory diseases like Parkinson's, Huntington's, ALS and Alzheimer's.

It was not clear if the binding between complement proteins and CNTs was direct or indirect. However, changing the surfaces of CNTs affected how likely the complement system was to be activated and in what way.

Using the data from this study, coated with genetically- engineered proteins are being used to target glioblastoma, the most aggressive form of brain tumour.

Dr Uday Kishore, from Brunel University London's College of Health and Life Sciences, said: "By using a protein recognised by the immune system to effectively disguise nanoparticles, we will be able to deploy these tiny particles to target hard-to- reach areas without damaging side effects to the patient. This is a big step forward. It is like understanding how to use penicillin safely and could be as revolutionary to modern medicine as its twentieth century predecessor."

Explore further: Biochemists identify molecular structures which allow the immune system to tell friend from foe

More information: "Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages." Nanomedicine: Nanotechnology, Biology and Medicine www.nanomedjournal.com/article … 4%2900112-9/fulltext

Related Stories

Tackling liver injury

August 11, 2014

A new drug spurs liver regeneration after surgery, according to a paper published in The Journal of Experimental Medicine.

New insight into common cause of blindness

November 14, 2014

(Medical Xpress)—Scientists at The University of Manchester have identified an important new factor behind one of the major causes of blindness, which they hope could lead to new treatments.

Recommended for you

Atomic blasting creates new devices to measure nanoparticles

December 14, 2017

Like sandblasting at the nanometer scale, focused beams of ions ablate hard materials to form intricate three-dimensional patterns. The beams can create tiny features in the lateral dimensions—length and width, but to create ...

Engineers create plants that glow

December 13, 2017

Imagine that instead of switching on a lamp when it gets dark, you could read by the light of a glowing plant on your desk.

Faster, more accurate cancer detection using nanoparticles

December 12, 2017

Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.